Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
03/2012
03/29/2012WO2012016980A3 Use of sigma ligands in opioid-induced hyperalgesia
03/29/2012WO2011152671A3 Pharmaceutical composition for the prevention or treatment of inflammatory diseases or immune diseases containing ramalin
03/29/2012WO2011150160A9 Method of preventing and treating inflammatory diseases and disorders with abscisic acid
03/29/2012WO2011140267A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-trna synthetase complex
03/29/2012WO2011140132A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-trna synthetases
03/29/2012WO2011139907A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases
03/29/2012WO2011139801A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of threonyl trna synthetases
03/29/2012WO2010111777A8 Novel sodium channel blocking compounds tetrodotoxin galactopyranosides
03/29/2012US20120078165 Element for implantation with medical device
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077858 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response
03/29/2012US20120077857 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/29/2012US20120077856 Pharmaceutical product
03/29/2012US20120077840 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
03/29/2012US20120077838 Beta-2-Adrenoreceptor Agonists
03/29/2012US20120077832 Besylate salt of a btk inhibitor
03/29/2012US20120077830 Caspase inhibitors and uses thereof
03/29/2012US20120077827 Zap-70 active compounds
03/29/2012US20120077822 In situ-formed bioactive tissue adherent films of absorbable crystallizable polymers
03/29/2012US20120077815 Fused Pyridine And Pyrazine Derivatives As Kinase Inhibitors
03/29/2012US20120077814 Sulfonamide, sulfamate, and sulfamothioate derivatives
03/29/2012US20120077808 Niacin Mimetics, and Methods of Use Thereof
03/29/2012US20120077807 Niacin mimetics, and methods of use thereof
03/29/2012US20120077798 Azetidine and cyclobutane derivatives as jak inhibitors
03/29/2012US20120077788 Use of telocinobufagin as an analgesic in the treatment of acute and chronic pains; pharmaceutical composition containing telocinobufagin and its use
03/29/2012US20120077785 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis
03/29/2012US20120077775 Macrocyclic compounds useful as inhibitors of kinases and hsp90
03/29/2012US20120077773 Use of a composition for the treatment of mucositis
03/29/2012US20120077764 Compositions and method for treating infection in cattle and swine
03/29/2012US20120077747 Fish-derived protein lysate, and uses thereof as immunomodulatory and/or anti-inflammatory agent
03/29/2012US20120077741 Treatment of Central Nervous System Disorders
03/29/2012US20120077734 Methods and assays for treating conditions in which macrophages play a pathogenic role
03/29/2012US20120077733 Antagonists against interaction of pf4 and rantes
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120076850 Topical Patch For Pain Relief Using Cooling Agent
03/29/2012US20120076841 Porous Particles Loaded with Cosmetically or Pharmaceutically Active Compounds
03/29/2012US20120076831 Compositions and methods for induction of antigen-specific tolerance
03/29/2012US20120076819 Compositions And Methods For Treating of Microbial Infections
03/29/2012US20120076809 Method to inhibit the biological activity of calcineurin with selective peptides
03/29/2012US20120076808 Combined antigen and dna vaccine for preventing and treating autoimmune diseases
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076782 Generation and profiling of fully human hucal gold®-derived therapeutic antibodies specific for human cd38
03/29/2012US20120076776 Method for treating inflamation by lymphocyte depletion or sequestering
03/29/2012US20120076773 Novel Drug Delivery Devices
03/29/2012US20120076769 Herbal composition for cancer treatment
03/29/2012US20120076755 Hepatitis C Virus Inhibitors
03/29/2012US20120076744 Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
03/29/2012US20120076742 Topical drug delivery system with dual carriers
03/29/2012US20120076739 Novel combination of anticholinergics-b2-adrenoceptor agonists, antileukotrienes (leukotriene receptor antagonists), glucocorticoids and/or phosphodiesterase 4 inhibitors for the treatment of inflammatory diseases
03/29/2012US20120076731 Lymphedema associated genes and model
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012DE102010046837A1 Phenylchinazolinderivate Phenylchinazolinderivate
03/29/2012CA2849382A1 Therapeutic applications of smad7
03/29/2012CA2812704A1 Formulations for bovine granulocyte colony stimulating factor and variants thereof
03/29/2012CA2812467A1 Atropisomers of pi3k-inhibiting compounds
03/29/2012CA2812319A1 Matrix metalloproteinase inhibitors
03/29/2012CA2810706A1 Substituted amide compound
03/29/2012CA2809217A1 Pyrimidones for treatment of potassium channel related diseases
03/29/2012CA2806121A1 Pharmaceutical composition
03/28/2012EP2434022A2 Use of A33 antigens and JAM-IT
03/28/2012EP2433649A2 Treatment of multiple sclerosis (MS) with campath-1H
03/28/2012EP2433631A2 Anti-inflammatory composition containing macrolactin a and a derivative thereof as active ingredients
03/28/2012EP2433630A1 Self-emulsifying composition of 3 fatty acid
03/28/2012EP2432776A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
03/28/2012EP2432765A1 Isoquinolin-1 (2h) -one derivatives as parp-1 inhibitors
03/28/2012EP2432763A1 1,4 dihydropyridine derivatives and their uses
03/28/2012EP2432495A2 Elastin for soft tissue augmentation
03/28/2012EP2432480A1 Compositions and methods for treating inflammatory arthritis
03/28/2012EP2432472A1 3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]octane- or heptane-nitrile as jak inhibitors
03/28/2012EP2432322A1 Optimal compositions and methods for treating oral disease and pain
03/28/2012EP2297148B8 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors
03/28/2012EP2252612B1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors
03/28/2012EP2148862B1 Dihydroquinone and dihydronaphthridine inhibitors of jnk
03/28/2012EP1603883B1 Quinoline-derived amide modulators of vanilloid vr1 receptor
03/28/2012EP1472234B1 Quinazolinone derivatives and their use as cb agonists
03/28/2012EP1453508B1 Tempamine compositions and use against cellular oxidative damage
03/28/2012EP1432707B1 Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
03/28/2012EP1117684B1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure
03/28/2012CN1635901B Remodeling and glycoconjugation of peptides
03/28/2012CN1583063B Extraction of effective components from frankinscene and its preparation and use
03/28/2012CN102395592A Isothiazolo-pyrimidinedione derivatives as trpa1 modulators
03/28/2012CN102395589A Fused pyrrolopyridine derivative
03/28/2012CN102395586A TRiazolopyridine derivatives as p38 map kinase inhibitors
03/28/2012CN102395585A Heteroaryls and their use as pi3k inhibitors
03/28/2012CN102395575A P38map kinase inhibitor
03/28/2012CN102395571A Novel triazine derivative and pharmaceutical composition containing same
03/28/2012CN102395562A Novel p2x7r antagonists and their use
03/28/2012CN102395560A Dihydrolipoic acid derivatives comprising nitric oxide and therapeutic uses thereof
03/28/2012CN102391499A Preparation method of polymer for quickly releasing active components of masticinic acid under exciting of reduction
03/28/2012CN102391389A Colloidal bismuth pectin compound and medicinal composition thereof, and preparation methods and application thereof
03/28/2012CN102391342A Dexamethasone palmitate compound and preparation method thereof
03/28/2012CN102391323A Tetrahydro-beta-carboline derivative, preparation method thereof and use thereof
03/28/2012CN102391251A Chemokine receptor antagonists
03/28/2012CN102391231A Flavonoid compound and application thereof in preparation of pharmaceutical preparation
03/28/2012CN102391107A Method for preparing gallic acid quinolone drug salt and preparation method thereof
03/28/2012CN102391095A Rheum emodin derivative and application thereof
03/28/2012CN102389561A Externally applied hot washing traditional Chinese medicinal composition for blood circulation invigorating and pain relieving and application thereof
03/28/2012CN102389552A External medicinal liquor used for treating rheumatic ostalgia
03/28/2012CN102389532A Pharmaceutical composition for treating pains in neck, shoulder, low-back and leg
1 ... 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 ... 1272